Searched for
VICTOZA
Novo Nordisk sued in US for allegedly monopolizing diabetes drug VictozaDanish drugmaker Novo Nordisk faces a class action lawsuit in New York. The company is accused of using its patents to keep a monopoly on i...- Cipla Q3 Results: Net profit plunges 57% YoY to Rs 676 croreCipla Q3 Results: Cipla reported a 57% YoY drop in net profit to Rs 676 crore, impacted by lower gRevlimid sales in North America. Despite ...
- Delhi HC seeks regulator's reply after PIL questions Ozempic, Mounjaro nodThe Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like Ozempic and Mounja...
- Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and WegovyBiocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canad...
- Biocon gets CDSCO nod for generic diabetes medicationBiocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, for treating Ty...
- Biocon shares in focus after CDSCO nod for diabetes drug LiraglutideBiocon shares are in focus as the company has received regulatory approval from the Central Drugs Standard Control Organisation for its dia...
- Novo Nordisk inks $2-billion obesity drug deal with United LabsNovo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different mechanisms in an effort...
- Biocon, Zentiva get EU approval for generic diabetes, weight management drugBiocon Ltd and Zentiva have secured decentralised procedure approval in the EU for Liraglutide, a complex formulation used for diabetes and...
- Weight-loss drugs didn't curb health costs within two years, data showU.S. health insurance claims analysis shows that two years after starting Novo Nordisk's Wegovy or similar GLP-1 drugs, annual medical cost...
- What other health conditions might weight-loss drugs treat?New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...
- Sajjala Bio to begin clinical trials on diabetes drugIn a statement, the Hyderabad-based company that reported Rs 15 crore of revenue last fiscal year, said it would soon take up clinical stud...
- Health to become more vital politically in India: Novo Nordisk CEO Lars Rebien Sørensen"India has a high incidence of non-communicable diseases, especially diabetes, and it is mostly because it is poorly regulated," said Søren...
- Eli Lilly launches once-a-week diabetes drug in IndiaThe once-a-week non-insulin injectable Trulicity is distinct in the duration of dosage compared to products like Novo Nordisk's Victoza or ...
- DIPP for extending provision of Compulsory Licences beyond cancer drugsThe move will drastically reduce prices of key drugs, but at the same time, jeopardise the plans of multinational drug companies.
- Novo to launch Victoza in Japan in JuneDenmark's Novo Nordisk said it would launch its potential blockbuster drug Victoza in Japan this month.
Load More
